{"id":1146,"date":"2023-12-22T04:55:56","date_gmt":"2023-12-22T04:55:56","guid":{"rendered":"https:\/\/o-force.info\/?page_id=1146"},"modified":"2025-02-21T02:04:14","modified_gmt":"2025-02-21T02:04:14","slug":"research-progress","status":"publish","type":"page","link":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/","title":{"rendered":"Research Progress"},"content":{"rendered":"\n<p class=\"has-large-font-size wp-block-paragraph\"><strong>Fiscal Year 2020<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Funding started by AMED Bridging Research Grant, Seeds A<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reserach on aggregation of 6 kinds of fragment peptides derived from amyloid-\u03b2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Screening of 150 synthetic peptides for their aggregation inhibitory effects<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patent application (Kochi University): Japan<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aggregation inhibition and aggregation disengagement peptide<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patent Application 2020-167404 \"Amyloid-\u03b2 aggregation inhibitor, pharmaceutical composition for amyloid-\u03b2 aggregation disease, and uses thereof\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reinforcing patent pending<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">No effect on \u03b1-synuclein (Parkinson's disease) or SOD1 (ALS), and specific for A\u03b225-35 (Alzheimer's disease)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Verification of pharmacological effects<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cognitive function assessment methods (Y-maze test, open field test, object recognition test, social-behavioral analysis)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Identification of peptides that improve cognitive function in a mouse model of A\u03b225-35 intrahippocampal administration<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Evaluation of motor function (Rotor Rod)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Identification of peptides that improve motor function in a mouse model of Syn61-84 intracerebroventricular administration<\/p>\n\n\n\n<p class=\"has-large-font-size wp-block-paragraph\"><strong>Fiscal Year 2021<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Funding continues by AMED Bridging Research Grant, Seeds A<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Started screening for ALS and Tau<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patent application (Kochi University): Japan<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aggregation inhibitor, aggregation disengagement peptide<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patent Application 2021-08513 \"Amyloid-\u03b2 aggregation inhibitor, pharmaceutical composition for amyloid-\u03b2 aggregation disease, and uses thereof\"<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patent&nbsp; Application 2021-08512 \"Aggregation inhibitor of \u03b1-synuclein, pharmaceutical compositions for \u03b1-synuclein aggregation diseases, and uses thereof\"<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Determining dosage and route of administration (research on effects in intranasal administration)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Safety (research on acute toxicity, chronic toxicity, and lethal dose)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Collaboration with companies<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">BioJapan (booth &amp; matching)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Joint research with domestic companies and a domestic pharmaceutical company<\/p>\n\n\n\n<p class=\"has-large-font-size wp-block-paragraph\"><strong>Fiscal Year 2022<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Started joint research with a domestic pharmaceutical company and Kochi University for clinical trials.<\/p>\n\n\n\n<p class=\"has-large-font-size wp-block-paragraph\"><strong>Fiscal Year 2023<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Intranasal administration of our peptides to Alzheimer's disease model mice improved cognitive function.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Intranasal administration of peptides to Parkinson's disease model mice suppressed mobility dysfunction.<\/p>\n\n\n\n<h2 class=\"wp-block-heading is-style-vk-heading-plain has-large-font-size\"><strong>Fiscal Year 202<\/strong>4<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Alzheimer's disease: Peptide (JAL-TA9) degraded amyloid-beta in the human brain slices.  Using monkeys, the concentration of JAL-TA9 in cerebrospinal fluid was measured, and its distribution was evaluated.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Parkinson's disease: Evaluation of peptide (PD-Cat) effect on pathological hallmarks of Parkinson's disease in human patient brain slices using immunohistochemical analysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Fiscal Year 2020 Funding started by AMED Bridging Research Grant, Seeds A Reserach on aggregation of 6 kinds o [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1144,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","vkExUnit_sitemap":"","_veu_custom_css":"","veu_display_promotion_alert":"common","_exclude_from_list_pages":"","vkexunit_cta_each_option":"","vkExUnit_childPageIndex":"","vkExUnit_pageList_ancestor":"","vkExUnit_contact_enable":"","footnotes":""},"class_list":["post-1146","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Fiscal Year 2020 Funding started by AMED Bridging Resea\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"ja_JP\" \/>\n\t\t<meta property=\"og:site_name\" content=\"O-Force Co., Ltd - \u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3092\u76ee\u6307\u3059\u4f1a\u793e\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Research Progress - O-Force Co., Ltd\" \/>\n\t\t<meta property=\"og:description\" content=\"Fiscal Year 2020 Funding started by AMED Bridging Resea\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-12-22T04:55:56+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-02-21T02:04:14+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Research Progress - O-Force Co., Ltd\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Fiscal Year 2020 Funding started by AMED Bridging Resea\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/research-progress\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info#listItem\",\"position\":1,\"name\":\"\\u30db\\u30fc\\u30e0\",\"item\":\"https:\\\/\\\/o-force.info\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/#listItem\",\"name\":\"Catalytide Research Lab\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/#listItem\",\"position\":2,\"name\":\"Catalytide Research Lab\",\"item\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/research-progress\\\/#listItem\",\"name\":\"Research Progress\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info#listItem\",\"name\":\"\\u30db\\u30fc\\u30e0\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/research-progress\\\/#listItem\",\"position\":3,\"name\":\"Research Progress\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/#listItem\",\"name\":\"Catalytide Research Lab\"}}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/research-progress\\\/#webpage\",\"url\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/research-progress\\\/\",\"name\":\"Research Progress - O-Force Co., Ltd\",\"description\":\"Fiscal Year 2020 Funding started by AMED Bridging Resea\",\"inLanguage\":\"ja\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/o-force.info\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/o-force.info\\\/index.php\\\/en\\\/catalytide-research-lab\\\/research-progress\\\/#breadcrumblist\"},\"datePublished\":\"2023-12-22T04:55:56+00:00\",\"dateModified\":\"2025-02-21T02:04:14+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/o-force.info\\\/#website\",\"url\":\"https:\\\/\\\/o-force.info\\\/\",\"name\":\"O-Force Co., Ltd\",\"description\":\"\\u30a2\\u30eb\\u30c4\\u30cf\\u30a4\\u30de\\u30fc\\u75c5\\u6cbb\\u7642\\u85ac\\u306e\\u958b\\u767a\\u3092\\u76ee\\u6307\\u3059\\u4f1a\\u793e\",\"inLanguage\":\"ja\",\"publisher\":{\"@id\":\"https:\\\/\\\/o-force.info\\\/#person\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Research Progress - O-Force Co., Ltd","description":"Fiscal Year 2020 Funding started by AMED Bridging Resea","canonical_url":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/o-force.info#listItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/o-force.info","nextItem":{"@type":"ListItem","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/#listItem","name":"Catalytide Research Lab"}},{"@type":"ListItem","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/#listItem","position":2,"name":"Catalytide Research Lab","item":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/","nextItem":{"@type":"ListItem","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/#listItem","name":"Research Progress"},"previousItem":{"@type":"ListItem","@id":"https:\/\/o-force.info#listItem","name":"\u30db\u30fc\u30e0"}},{"@type":"ListItem","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/#listItem","position":3,"name":"Research Progress","previousItem":{"@type":"ListItem","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/#listItem","name":"Catalytide Research Lab"}}]},{"@type":"WebPage","@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/#webpage","url":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/","name":"Research Progress - O-Force Co., Ltd","description":"Fiscal Year 2020 Funding started by AMED Bridging Resea","inLanguage":"ja","isPartOf":{"@id":"https:\/\/o-force.info\/#website"},"breadcrumb":{"@id":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/#breadcrumblist"},"datePublished":"2023-12-22T04:55:56+00:00","dateModified":"2025-02-21T02:04:14+00:00"},{"@type":"WebSite","@id":"https:\/\/o-force.info\/#website","url":"https:\/\/o-force.info\/","name":"O-Force Co., Ltd","description":"\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3092\u76ee\u6307\u3059\u4f1a\u793e","inLanguage":"ja","publisher":{"@id":"https:\/\/o-force.info\/#person"}}]},"og:locale":"ja_JP","og:site_name":"O-Force Co., Ltd - \u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3092\u76ee\u6307\u3059\u4f1a\u793e","og:type":"article","og:title":"Research Progress - O-Force Co., Ltd","og:description":"Fiscal Year 2020 Funding started by AMED Bridging Resea","og:url":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/","article:published_time":"2023-12-22T04:55:56+00:00","article:modified_time":"2025-02-21T02:04:14+00:00","twitter:card":"summary","twitter:title":"Research Progress - O-Force Co., Ltd","twitter:description":"Fiscal Year 2020 Funding started by AMED Bridging Resea"},"aioseo_meta_data":{"post_id":"1146","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-12-22 04:55:57","updated":"2025-06-25 04:45:01","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/o-force.info\" title=\"\u30db\u30fc\u30e0\">\u30db\u30fc\u30e0<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/\" title=\"Catalytide Research Lab\">Catalytide Research Lab<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tResearch Progress\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u30db\u30fc\u30e0","link":"https:\/\/o-force.info"},{"label":"Catalytide Research Lab","link":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/"},{"label":"Research Progress","link":"https:\/\/o-force.info\/index.php\/en\/catalytide-research-lab\/research-progress\/"}],"veu_head_title_object":{"title":"","add_site_title":""},"_links":{"self":[{"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/pages\/1146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/comments?post=1146"}],"version-history":[{"count":8,"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/pages\/1146\/revisions"}],"predecessor-version":[{"id":2091,"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/pages\/1146\/revisions\/2091"}],"up":[{"embeddable":true,"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/pages\/1144"}],"wp:attachment":[{"href":"https:\/\/o-force.info\/index.php\/wp-json\/wp\/v2\/media?parent=1146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}